RA flare while on methotrexate — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Short bridging course of glucocorticoid and optimise DMARD therapy
A short course of glucocorticoid can be used as bridging therapy while DMARD adherence, dose and escalation are reviewed. Stopping methotrexate permanently would risk loss of disease control without evidence of toxicity. Flares need infection exclusion, then a treat-to-target review rather than symptomatic treatment alone.
Reference: NICE NG100; BSR biologic DMARD safety guideline; BNF